Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients-Reference-Cited by-同舟云学术

Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients

Published:2017-11-06 Issue:63 Volume:8 Page:107052-107075
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Greene Christopher J.¹,Attwood Kristopher²,Sharma Nitika J.¹,Gross Kenneth W.³,Smith Gary J.¹,Xu Bo⁴,Kauffman Eric C.¹⁵⁶

Affiliation:

1. Department of Urology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA

2. Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA

3. Department of Molecular and Cellular Biology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA

4. Department of Pathology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA

5. Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA

6. Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14214, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new strategy for Astragaloside IV in the treatment of diabetic kidney disease: Analyzing the regulation of ferroptosis and mitochondrial function of renal tubular epithelial cells;International Immunopharmacology;2024-11

2. Identification of TFRC as a biomarker for pulmonary arterial hypertension based on bioinformatics and experimental verification;Respiratory Research;2024-08-03

3. An affordable label-free ultrasensitive immunosensor based on gold nanoparticles deposited on glassy carbon electrode for the transferrin receptor detection;International Journal of Biological Macromolecules;2024-07

4. Machine learning and 4D-LFQ quantitative proteomic analysis explore the molecular mechanism of kidney stone formation;Heliyon;2024-07

5. Article review: Brazilin as potential anticancer agent;Frontiers in Pharmacology;2024-03-07